Bayer considering sale of Animal Health business (€6-7bn)

Bayer considering sale of Animal Health business (€6-7bn)

Source: 
GoinPharma
snippet: 

Werner Baumann, CEO of Germany-based group Bayer, has told in an interview that his company’s management is assessing a sale of the Animal Health division. The segment last year delivered €1.6bn, with a 24% EBITDA.